Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-04-26 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第四次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the independent directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. regarding their prior approval opinions on matters to be discussed at the company's third board of directors' fourth meeting. It includes opinions on the proposal to renew the company's 2022 audit firm and on expected 2022 routine related-party transactions. The document is short (782 characters) and does not contain actual financial statements or detailed audit results, but rather opinions and approvals related to audit firm appointment and related-party transactions. This fits the category of Board/Management Information (MANG), as it concerns board meeting matters and approvals by independent directors, not the audit report itself or the annual report. Therefore, the appropriate classification is MANG with high confidence.
2022-04-26 Chinese
关于召开2021 年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2021 Annual General Meeting (AGM) of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed and voted on at the AGM, including reports and proposals related to the 2021 fiscal year, such as the board report, supervisory report, annual report, financial budget, equity distribution plan, auditor appointment, and amendments to the company charter. The document does not contain the actual reports or financial statements but references where these can be found. The document is primarily an announcement and notification for shareholders about the AGM and its agenda, including voting procedures and registration details. It fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or notices about the AGM itself. The document length is under 5,000 characters and is a detailed notice rather than the full annual report or financial statements. Therefore, the correct classification is AGM Information (AGM-R).
2022-04-26 Chinese
关于拟修订公司章程公告
Governance Information Classification · 95% confidence The document is an announcement regarding the proposed amendments to the company's Articles of Association (公司章程). It details specific changes to registered capital and share capital, referencing relevant laws and regulations. The document states that the amendments require shareholder approval at a general meeting. It is not a full report but a regulatory announcement about governance changes. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices. The document length is short and focused on governance amendments, not a full annual or interim report or a proxy solicitation.
2022-04-26 Chinese
中泰证券股份有限公司关于内蒙古大唐药业股份有限公司预计2022年日常性关联交易的核查意见
Regulatory Filings
2022-04-26 Chinese
2021年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled '2021 年度独立董事述职报告' which translates to '2021 Annual Independent Directors' Report'. It details the attendance and activities of independent directors during the year 2021, including their opinions on various board meeting proposals and their efforts to protect shareholder interests. The content focuses on the independent directors' duties and their report on their work for the year, rather than financial statements or audit results. This type of document is a report by the board members (independent directors) about their management and supervisory activities, which fits the category of Board/Management Information (MANG). The document length is 2017 characters, which is relatively short and consistent with a management or board report rather than a full annual report or audit report. There is no indication that this is a call transcript, earnings release, or other categories. Therefore, the best classification is MANG with high confidence.
2022-04-26 Chinese
2021 年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2021年度募集资金存放与实际使用情况的专项报告" which translates to "2021 Annual Report on the Deposit and Actual Use of Raised Funds." It details the amount of funds raised, their usage, management, and compliance with regulatory requirements. It includes specific financial figures related to fundraising, usage, and investment of idle funds, as well as audit and sponsor institution opinions. The document is a specialized report focusing on the use of capital raised by the company, not a general annual report or earnings release. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is sufficient and contains substantive financial data about fundraising and usage, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2022-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.